However, the degradation of IκB-α was observed in T+5-FU+Pro and T+5-FU+RS-Pro mice, suggesting that probiotics or RS-encapsulated probiotics may lead to the degradation of IκB-α and the activation of NF-κB in tumor tissues. The gene discussed is NFKB1; the disease is neoplasm.